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Abstract 
For a long time, the relationships between epilepsy and mood disorders captured the 
attention of clinicians and neuroscientists. The existence of a peculiar clinical 
presentation for mood disorders in epilepsy has been matter of debate since the early 
reports of Kraepelin and Bleuler. The interictal dysphoric disorder (IDD) represents the 
modern reinterpretation of such early observations. This paper reviews current 
research on this topic discussing clinical implications, phenomenological observations 
and directions for future research.  
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1. Introduction 
For a long time the association between epilepsy and depression has been matter 
of debate. In his famous quotation, Hippocrates report that “melancholics ordinarily 
become epileptics, and epileptics, melancholics: what determines the preference is the 
direction the malady takes; if it bears upon the body, epilepsy, if upon the intelligence, 
melancholy” [1]. This ancient observation has been recently revitalized by modern 
epidemiological data suggesting a bidirectional relationship between epilepsy and mood 
disorders and between epilepsy and suicide [2-4]. Although such a bidirectional link 
seems to be present in several chronic conditions, for example Parkinson’s disease [5], 
stroke [6], dementia [7], diabetes [8] and cardiovascular diseases [9], the case of 
epilepsy is definitely intriguing given the neurobiological underpinning shared by the 
two conditions [10-12].  
If epilepsy and depression share a number of pathophysiological mechanisms, it 
is also possible that there would be a peculiar syndrome characterized by seizures and 
mood symptoms. Epilepsy is not a unique entity, with a number of syndromes 
characterized by recurrent seizures as the main element. However, behavioral 
symptoms are rarely considered as part of whole picture. The concept of interictal 
dysphoric disorder (IDD) derives from original observations of classic German 
psychiatrists, namely Kraepelin and Bleuler, who observed that patients with untreated 
epilepsy could develop a pleomorphic pattern of depressive symptoms intermixed with 
euphoric moods, irritability, fear and anxiety as well as anergia, pain and insomnia [13, 
14]. This concept has been subsequently rejuvenated, in modern times, by Blumer who 
actually coined the term IDD [15]. Since its introduction, the concept of IDD has been 
matter of debate. The aim of this paper is discussing current research on this affective-
somatoform syndrome with special attention to clinical implications. References were 
identified by searches of Medline/PubMed using the key words “epilepsy”, “depression”, 
“interictal dysphoric disorder”. Only papers written in English have been considered. 
However, the list of relevant articles was hand-searched for additional publications (e.g. 
book chapters or review papers) if relevant for the discussion. 
 
2. The non-conforming features of mood disorders in epilepsy and the concept of 
IDD 
A number of authors agree that up to 50% of patients with epilepsy and depression 
present psychiatric symptoms that are not captured by standardized classificatory systems 
such as DSM or ICD [16-20]. This observation might explain the high variability in 
epidemiological data on mood disorders in epilepsy. In fact, community-based studies report 
prevalence rates in the order of 20%-22% [21, 22] but, in selected populations, such as 
tertiary referral centers, prevalence rates seem to be as high as 50% [23, 24]. Although it is 
plausible that such differences reflect the severity of the individual seizure disorder [25, 26], it 
is also possible that atypical presentations of depression are not captured by international 
coding systems or standardized clinical instruments. 
IDD is operatively conceptualized by Blumer in eight key symptoms, grouped in 
three major categories, namely labile depressive symptoms (depressive mood, anergia, 
pain, and insomnia), labile affective symptoms (fear, anxiety), and supposedly "specific" 
symptoms (paroxysmal irritability, and euphoric moods) (Table 1). The latter, in 
particular, identify a peculiar symptom cluster characterized by periodical mood 
changes and outbursts of irritability and aggressive behavior. Such episodes are 
described as occurring without external triggers and without clouding of consciousness, 
beginning and ending rapidly and recurring fairly regularly in a uniform manner (every 
few days to every few months and lasting a few hours up to 2 days). Interestingly, the 
concept of IDD goes beyond the mood disorder per se, encompassing a spectrum of 
conditions with transient psychotic features or even prolonged psychotic states. In other 
words, Blumer suggests that interictal psychoses of epilepsy represent severe forms of 
IDD with prominent psychotic features [15, 27]. 
Although it appears evident that Blumer’s description has been highly influenced 
by the Kraepelinian view of the relationship between mood disorders and 
schizophrenia, modern studies on the phenomenology of IDD and psychoses of epilepsy 
partly support this hypothesis. In fact, IDD seems to be closer to bipolar depression 
rather than to unipolar one [20, 28, 29] and psychoses of epilepsy are characterized by a 
preserved personality and prominent mood symptoms [30] suggesting that psychoses of 
epilepsy belong to the mood spectrum rather than to the psychotic spectrum. However, 
the symptom cluster described in patients with IDD and epilepsy is quite peculiar and is 
rarely reported in psychiatric practice even in rapid cycling bipolar disorders or 
cyclothymia [28]. Probably for this reason, Blumer stated that IDD is unique for epilepsy 
[27].  
 
3. The concept of peri-ictal dysphoric syndrome (PDS) 
It seems now established that epileptic seizures are not just characterized by the 
ictal phase but a number of behavioral manifestations can occur around the ictus, either 
preceding or following [31, 32]. Such symptoms may be subtle and difficult to identify if 
not specifically sought. In addition, they often fail to meet temporal criteria for mood 
symptoms according to DSM. It is, thus, evident that such manifestations are highly 
responsible for the atypical presentation of mood disorders in epilepsy.  
A cross-sectional study in patients with epilepsy report that most of the pleomorphic 
features of IDD are related to peri-ictal symptoms [33]. In fact, among patients with a 
diagnosis of IDD, about 50% present symptoms with a clear-cut relationship with 
epileptic seizures either presenting pre-ictally or post-ictally [33]. Premonitory 
symptoms are reported by one-third of patients with temporal lobe epilepsy, usually 
preceding secondary generalized tonic-clonic seizures [34]. Prodromal mood changes 
may occur hours to days before a seizure and are often relieved by the convulsion [35]. 
A cross-sectional study in tertiary referral centers in Europe point out that around 13% 
of patients may experience irritability, dysphoria or depressed mood preceding seizures 
[33]. As for pre-ictal symptoms, post-ictal mood changes are rarely recognized by 
clinicians but a case series of presurgical patients suggests that up to 18% of patients 
can report post-ictally at least five symptoms of depression lasting more than 24 hours 
and up to 22% present manic symptoms often with associated hallucinations or 
delusions [36]. Post-ictal anxiety seems to be even more frequent being reported by 
45% of patients [36]. The median duration of symptoms ranges from 6 to 24 hours but 
in one third of cases, post-ictal anxiety may last 24 hours or longer.  
All these data taken together have relevant implications in terms of prognosis 
and treatment, emphasizing the need to dissect out peri-ictal manifestations from 
interictal ones. It is estimated that around 12% of patients with TLE may present 
isolated peri-ictal dysphoric symptoms without interictal chronic symptoms [33]. In 
such patients a so-called peri-ictal dysphoric syndrome (PDS) can be recognized but the 
prognosis and treatment is that of the epileptic syndrome rather than that of a 
psychiatric disorder.  
 
4. Diagnosing IDD and PDS 
Peri-ictal symptoms are not rare but clinicians need to specifically enquire [29]. 
Moreover, peri-ictal symptoms may be almost indistinguishable from interictal ones, 
apart from duration and the close relation with seizure occurrence. It is, thus, possible, if 
not recognized, to overestimate psychiatric diagnosis or even misdiagnose behavioral 
problems in some cases. A cross sectional study of patients recruited in two epilepsy 
centers in Europe shows that a diagnosis of bipolar disorder may be overestimated in 
epilepsy if peri-ictal mood changes are not correctly identified [29]. In fact, out of the 
11.8% of DSM-based diagnoses of bipolar disorder, only 1.4% could be considered as a 
“pure” psychiatric diagnosis because in all other cases manic/hypomanic symptoms 
were temporally-related to seizures occurring either post-ictally or pre-ictally [29]. A 
careful assessment of seizure-based behavioral manifestations should always be part of 
a routine assessment of patients with epilepsy and behavioral problems. In fact, the 
identification of patients with PDS may be relevant in terms of localizing and prognostic 
value. In fact, post-ictal mania seems to be associated with frontal, non-dominant 
involvement [37, 38] and is associated with a poor prognosis after surgery identifying 
temporal lobe “plus” patients [38]. In this regard, a specific clinical instrument for the 
evaluation of IDD and PDS has been developed, namely the Interictal Dysphoric Disorder 
Inventory (IDDI) [20]. The IDDI is a 38 items, self-report questionnaire exploring a time-
interval of 12 months. It is possible to obtain a total score and three subscale scores that 
mirror the three major symptom categories described by Blumer. Besides, the IDDI 
measures the degree of interference or distress caused by IDD symptoms. The 
instrument shows a good internal consistency, an acceptable sensitivity and an excellent 
specificity. Finally, in the Appendix to the questionnaire, six questions investigate the 
time course of the disorder, duration of dysphoric symptoms and their associations with 
seizures or antiepileptic drug therapy. A recent study investigated test-retest reliability 
of the IDDI showing a 50% agreement [39]. This is something frequently seen in 
psychological testing as the attribute that is being measured may change between the 
first test and the retest; because the experience of taking the test itself can change a 
person’s true score. (for example, completing an anxiety inventory could serve to 
increase a person’s level of anxiety); finally because when retested, people may 
remember their original answer, which could affect answers on the second 
administration in order to minimize some symptoms. In the case of PDS, this is further 
complicated by the seizure itself as it is entirely possible that patients do not remember 
some symptoms that are part of the post-ictal state. For all these reasons a careful 
clinical evaluation should be part of the assessment apart from the use of clinical rating 
scales.  
 
5. Is IDD nosologically independent from other psychiatric syndromes? 
 
 Whether IDD is a nosologically independent psychopathological construct 
represents the key question.  That up to 50% of patients with epilepsy and mood 
disorders do not meet DSM criteria do not necessarily mean that all of them have IDD. A 
cross sectional study aimed at validating IDD against DSM criteria showed that patients 
with IDD fulfill criteria for a specific DSM diagnosis [20] and this has been replicated by 
other studies other centres [39, 40]. In addition, IDD was shown also inb patients with 
migraine with a fairly similar prevalence [20] suggesting that it is not disease-specific. 
However, studies aimed at investigating the impact of IDD on quality of life clearly 
showed that IDD and DSM depressive disorders have a different impact [39-41]. An 
interesting observation comes from a cross-sectional study aimed at investigating 
temperamental features of patients with epilepsy [42]. The authors showed that 
irritable and dysphoric features are more prevalent in the epilepsy population as 
compared to the general population. The term temperament refers to those aspects of 
an individual's personality that are regarded as innate rather than learned. It is now 
established that affective temperaments represents the main neurobiological ground on 
which mood disorders develop. In addition, affective temperaments influence the 
clinical features of a specific mood disorder in terms of both clinical and course 
characteristics, family history and axis I and II co-morbidities [43]. It is, thus, possible 
that the ultimate phenotype for mood disorders in epilepsy is shaped by an underlying 
dysphoric/irritable temperament making the flavor of depression in epilepsy different 
from that of typical endogenous depression. The identification of such clinical 
dimensions is not an academic exercise but has relevant implications in terms of suicidal 
risk [41] and post-surgical complications [45]. Whether the irritable temperament type 
is more prevalent in epilepsy as compared to other chronic medical conditions hasn’t 
been established yet. Amygdala volume loss seem to be related to IDD in epilepsy [46] 
but whether this is typical of epilepsy only or it represents an anatomical correlates of 
mood dysfunction with dysphoria has to be established. Further studies aimed at 
investigating the relationship between temperamental features and chronic medical and 
neurological disorders are urgently needed. 
 
6. Conclusions 
The concept of IDD has been matter of discussion for a long time. However, a few 
points seem to be clearly established: (1) patients with epilepsy may present behavioral 
syndromes with atypical features compared to those currently described in wisely used 
classificatory systems such as DSM; (2) in several cases, such atypical features are 
related to peri-ictal symptoms that may not be captured or misleadingly captured by 
standardized clinical instruments adopted outside epilepsy; (3) peri-ictal symptoms are, 
by definition, typical of epilepsy, and as such, epilepsy-specific behavioral syndromes 
are plausible.   
Further studies are needed in order to identify a peculiar clinical phenotype and 
its clinical characteristics. Epilepsy still today represents a privileged window into the 
neurobiology of behavior and mood.   
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Table 1. Symptom clusters for interictal dysphoric disorder. 
 
Labile depressive symptoms 
Depressed mood 
Anergia 
Pain 
Insomnia 
 
Labile affective symptoms 
Fear 
Anxiety 
 
Specific symptoms 
Mood swings  
Paroxysmal irritability 
Euphoric moods 
 
 
 
 
 
 
 
 
 
 
 
